Delivery Order SPE2DB20D2014-SPE2DB24FC83P

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM to the Defense Logistics Agency (DLA), a defense agency. The $1,296.00 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 23, 2025, with a completion date of May 27, 2025. This delivery order contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is a Delivery Order valued at $1,944.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM, a pharmaceutical product, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Testosterone 1% (25mg/2.5g) packaged in individual units. The contract, valued at $1,117.08, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 6, 2024. It is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen will provide this testosterone medication product to support the healthcare needs...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of testosterone 1% (25mg/2.5g) in 2.5g packages, with a ceiling value of $1,296.00 and a period of performance through April 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of testosterone 1% (50 mg/5 g) in a 5 g package, with a ceiling value of $1,031.07 and a completion date of June 17, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.96, is a Firm Fixed Price Delivery Order for the supply of TESTOSTERONE 1% (50 MG/5 G) PK UD 5GM, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. No set-aside designation was used for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,757.58, is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical products. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical products to the Defense Logistics Agency (DLA). The $3,132.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,384.60, is for the delivery of testosterone 1% (50 mg/5 g) product in units of 5 grams. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 27, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Testosterone 1% (25mg/2.5g) in 2.5g packs. The contract is a firm-fixed-price delivery order with a ceiling value of $3,800.88 and a period of performance ending on March 10, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC83P
    Delivery Order

This federal contract award is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK UD 2.5GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $3,673.92. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The award has no set-aside designation and is scheduled for completion on August 23, 2024.

Generated 11/21/24, 9:19 AM